NIPT Laboratories Don't Follow All ACMG Recommendations for Reporting, Patient Education

Apr 03, 2019

|

NEW YORK (GenomeWeb) – Commercial laboratories offering cell-free DNA-based noninvasive prenatal testing (NIPT) in the US do not follow all recommendations put forward by the American College of Medical Genetics and Genomics in 2016, a new study has found. According to the authors, this may lead to confusion and improper counseling.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.

Menu

NIPT Laboratories Don't Follow All ACMG Recommendations for Reporting, Patient Education

To read the full story....

Breaking News

FDA Adds At-Home Self-Collection Template to SARS-CoV-2 Emergency Use Authorization Guidance

BTIG Initiates Coverage of Fulgent Genetics

Tangen Biosciences, LabWare Partner on Point-of-Care Coronavirus Kit

Progenity Files for IPO, Seeks to Raise up to $100M

LetsGetChecked At-Home Molecular SARS-CoV-2 Test Nabs FDA Emergency Use Authorization

OraSure Technologies to Acquire HIV Drug Adherence Test Developer UrSure

Featured White Papers

COVID-19 Testing, Treatment and Future Outlook

Diagnostic Challenges in Cancer Immunotherapy: An Expert Panel Discussion

What's Popular?

FDA Adds At-Home Self-Collection Template to SARS-CoV-2 Emergency Use Authorization Guidance

AMP SARS-CoV-2 Molecular Dx Survey Shows Supply Chain Issues Hampered Ramp Up of Testing

FDA Releases Reference Panel for Coronavirus Test Developers

LetsGetChecked At-Home Molecular SARS-CoV-2 Test Nabs FDA Emergency Use Authorization

With Low-Cost SARS-CoV-2 Assay, FYR Diagnostics Looks to Bypass Equipment Bottlenecks

Sponsorships